Sign in

Private company

European Organisation for Research and Treatment of Cancer

Logo: EORTC, CC BY-SA 4.0, via Wikimedia Commons3

International nonprofit organization

The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients.2 It is headquartered in Woluwe-Saint-Lambert.1 Its revenue was €41.1 million in 2020.1 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

1962Founded1
  • HeadquartersWoluwe-Saint-Lambert1
  • Websitewww.eortc.org
  • Legal forminternational non-profit association1

See how the biggest companies compare on our leaderboards

The European Organisation for Research and Treatment of Cancer (EORTC) is a unique pan-European non-profit clinical cancer research organisation established in 1962 operating as an international association under Belgium law. It develops, conducts, coordinates and stimulates high-quality translational and clinical trial research to improve the survival and quality of life of cancer patients. This is achieved through the development of new drugs and other innovative approaches, and the testing of more effective therapeutic strategies, using currently approved drugs, surgery and/or radiotherapy in clinical trials conducted under the auspices of a vast network of clinical cancer researchers supported by 220 staff members based in Brussels. The EORTC has the expertise to conduct large and complex trials especially specific populations such as the older patient and rare tumours.2

Products and brands

The EORTC's mission is to increase people's survival and quality of life by testing new therapeutic strategies based on existing drugs, surgery and radiotherapy. The EORTC also helps develop new drugs and approaches in partnership with the pharmaceutical industry and in patients' best interests.

EORTC achievements

In order to adapt to the changing landscape of clinical trial design, the EORTC has developed a number of platforms, which will facilitate more cost effective and efficient trials and gather important information to provide better treatment and care to cancer patients and survivors. These platforms include SPECTA-molecular screening of patients, SUCARE- evaluating quality assurance in surgical oncology, E2-RADIATE- evaluating quality assurance in radiation oncology and the YOU (Your Outcome Updates) protocol that will gather data on long term long-term medical, psychological and socio-economic outcomes of patients treated in clinical trials.

Its network

Read the full text

The EORTC research network consists of over 3,900 collaborators from all disciplines involved in cancer treatment and research in more than 930 institutions in 63 countries. Its research spans the entire spectrum from translational and preclinical research to large, prospective, multi-centre, phase III clinical trials that evaluate new cancer therapies and/or treatment strategies as well as patient quality of life. Currently, the EORTC is conducting 167 studies, and thousands of patients (85% from within the EU) participate in EORTC clinical trials. 25,000 patients continue to be followed on a yearly basis, and the EORTC clinical study database now contains outcome data for over 190,000 cancer patients.

Alongside the EORTC scientific and clinical programme, the EORTC collaborates with a number of international organisations, including the US National Cancer Institute, National Cancer Institute Canada, and other countrywide groups. Also a number of academic societies such as European Society for Therapeutic Radiation Oncology, European Society of Surgical Oncology, European Society of Medical Oncology and European Society of Paediatric Oncology. In order to follow changing regulatory requirements, the EORTC regularly converses with the US Food and Drug Administration and the European Medicines Evaluation Agency.

From Wikipedia’s article on European Organisation for Research and Treatment of Cancer, shared under CC BY-SA 4.0.4

Revenue over time

As stated on Wikidata, in the currency reported.

Revenue

  • 202041.1M EUR1

Timeline

  1. 1962Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4